By Da Hee Han, PharmD
BOSTON, MA—Interferon (IFN)-free direct-acting antiviral agent (DAA) regimens are “as safe and effective” for elderly patients with hepatitis C virus (HCV)-related cirrhosis or severe fibrosis as they are for younger patients, according to research presented at The Liver Meeting® 2016.
“The lifetime utility of HCV eradication in the elder in terms of reduction of events and overall survival needs evaluation in long-term observational cohorts,” however, cautioned senior study author Vincenza Calvaruso, MD, PhD, of the University of Palermo, in Palermo, Italy.
Continue reading...
DAAs Effective for Chronic HCV, Even in Very Elderly
By Da Hee Han, PharmD November 14, 2016
BOSTON, MA—“Advanced age in and of itself should not be considered a barrier to direct-acting antiviral (DAA) treatment” in patients with chronic hepatitis C virus (HCV) infection, a study in more than 17,000 veterans presented at The Liver Meeting® 2016 concluded.
“DAAs are equally highly effective for the treatment of chronic HCV in all age groups, including very elderly patients,” added Feng Su, MD, University of Washington, Seattle, WA and Veterans Affairs Puget Sound Healthcare System, Seattle, WA, and colleagues.
Continue reading....
No comments:
Post a Comment